# Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

> **NCT00268970** · PHASE2 · COMPLETED · sponsor: **Agennix** · enrollment: 40 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Satraplatin in combination with Paclitaxel

## Key facts

- **NCT ID:** NCT00268970
- **Lead sponsor:** Agennix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-04
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268970, "Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00268970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*